STOCK TITAN
  1. Home
  2. Sec-filings
  3. THC
  4. [Form 4] TENET HEALTHCARE CORP Insider Trading Activity

Tenet Healthcare (THC) accounting officer reports 8,017-share stock sale

Filing Impact
(Very High)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Tenet Healthcare principal accounting officer Scott R. Ramsey reported multiple stock transactions. On March 2, 2026, he completed open-market sales totaling 8,017 shares of common stock at weighted average prices of about $230.98, $233.21, and $233.69, leaving 5,892 shares owned directly. Earlier, on February 27, 2026, restricted stock units from 2023 and 2024 grants converted one-for-one into common shares, and several transactions labeled as tax-withholding dispositions satisfied taxes due on these vestings.

Positive

  • None.

Negative

  • None.
Insider Ramsey R. Scott
Role Principal Accounting Officer
Sold 8,017 shs ($1.87M)
Approx. gross sale proceeds $1.87M
Approx. exercise cost $0.00
Type Security Shares Price Value
Sale Common Stock 2,125 $230.98 $491K
Sale Common Stock 4,494 $233.21 $1.05M
Sale Common Stock 1,398 $233.69 $327K
Exercise 2024 February Restricted Stock Units 934 $0.00 $0.00
Exercise 2023 March Restricted Stock Units 1,400 $0.00 $0.00
Exercise Common Stock 934 $0.00 $0.00
Exercise Common Stock 1,400 $0.00 $0.00
Exercise Price or Tax Liability Common Stock 175 $237.58 $42K
Exercise Price or Tax Liability Common Stock 919 $239.39 $220K
Exercise Price or Tax Liability Common Stock 3,114 $239.39 $745K
Holdings After Transaction: 2024 February Restricted Stock Units — 935 shares (Direct); 2023 March Restricted Stock Units — 0 shares (Direct); Common Stock — 0 shares (Direct)
Footnotes (12)
  1. F1. Restricted stock units convert into common stock on a one-for-one basis.
  2. F2. Reflects shares delivered by reporting person to satisfy withholding taxes due upon vesting of performance share units.
  3. F3. Represents the closing price of the common stock of the Issuer on the vesting date for the award.
  4. F4. Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3.
  5. F5. Represents the closing price of the common stock of the Issuer on February 27, 2026.
  6. F6. The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 28, 2024, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the second 1/3 increment vested on February 27, 2026 (the business day prior to February 28, 2026, which fell on a weekend).
  7. F7. Time-based restricted stock units are settled in shares of the Company's common stock upon vesting.
  8. F8. The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on March 1, 2023, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the third 1/3 increment vested on February 27, 2026 (the business day prior to March 1, 2026, which fell on a weekend).
  9. F9. The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $230.78 to $231.68.
  10. F10. The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $232.52 to $233.32.
  11. F11. The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $233.60 to $234.28.
  12. F12. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →

FAQ

What insider stock transactions did Tenet Healthcare (THC) report for Scott R. Ramsey?
Tenet Healthcare reported that principal accounting officer Scott R. Ramsey sold 8,017 shares of common stock and also had restricted stock units vest and convert into shares, with some of those shares withheld to cover tax obligations related to the vesting events.

How many Tenet Healthcare (THC) shares did Scott R. Ramsey sell and at what prices?
Scott R. Ramsey sold a total of 8,017 Tenet Healthcare common shares in open-market transactions at weighted average prices of approximately $230.98, $233.21, and $233.69 per share, as disclosed in the Form 4 insider trading report.

How many Tenet Healthcare (THC) shares does Scott R. Ramsey own after these transactions?
After the reported sales and vesting-related transactions, Scott R. Ramsey directly owns 5,892 shares of Tenet Healthcare common stock, according to the share balances listed following the final open-market sale on March 2, 2026.

What happened to Scott R. Ramsey’s Tenet Healthcare restricted stock units?
Restricted stock units granted in March 2023 and February 2024 converted into Tenet Healthcare common stock on a one-for-one basis upon vesting on February 27, 2026, consistent with the company’s 2019 Stock Incentive Plan terms described in the footnotes.

Why were some Tenet Healthcare (THC) shares disposed of as tax-withholding transactions?
Shares labeled with transaction code F were withheld or delivered to cover tax liabilities and related obligations triggered by the vesting of restricted stock and performance share units, using the issuer’s common stock closing prices specified in the footnotes.

What do the price range footnotes mean in the Tenet Healthcare (THC) Form 4?
The footnotes explain that reported sale prices are weighted averages for multiple trades, with detailed prices ranging within specified bands. Scott R. Ramsey offers to provide exact share counts at each separate price to the company, shareholders, or SEC staff upon request.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Ramsey R. Scott
(Last) (First) (Middle)
14201 DALLAS PARKWAY
(Street)
DALLAS TX 75254
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
TENET HEALTHCARE CORP [ THC ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Principal Accounting Officer
3. Date of Earliest Transaction (Month/Day/Year)
02/27/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 02/27/2026 M 934 A (1) 10,825 D
Common Stock 02/27/2026 M 1,400 A (1) 12,225 D
Common Stock 02/27/2026 F 175(2) D $237.58(3) 12,050 D
Common Stock 02/27/2026 F 919(4) D $239.39(5) 11,131 D
Common Stock 02/27/2026 F 3,114(2) D $239.39(5) 8,017 D
Common Stock 03/02/2026 S 2,125 D $230.98(9)(12) 5,892 D
Common Stock 03/02/2026 S 4,494 D $233.21(10)(12) 1,398 D
Common Stock 03/02/2026 S 1,398 D $233.69(11)(12) 0 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
2024 February Restricted Stock Units (6) 02/27/2026 M 934 (6) (6) Common Stock(7) 934 $0 935 D
2023 March Restricted Stock Units (8) 02/27/2026 M 1,400 (8) (8) Common Stock(7) 1,400 $0 0 D
Explanation of Responses:
1. Restricted stock units convert into common stock on a one-for-one basis.
2. Reflects shares delivered by reporting person to satisfy withholding taxes due upon vesting of performance share units.
3. Represents the closing price of the common stock of the Issuer on the vesting date for the award.
4. Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3.
5. Represents the closing price of the common stock of the Issuer on February 27, 2026.
6. The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 28, 2024, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the second 1/3 increment vested on February 27, 2026 (the business day prior to February 28, 2026, which fell on a weekend).
7. Time-based restricted stock units are settled in shares of the Company's common stock upon vesting.
8. The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on March 1, 2023, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the third 1/3 increment vested on February 27, 2026 (the business day prior to March 1, 2026, which fell on a weekend).
9. The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $230.78 to $231.68.
10. The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $232.52 to $233.32.
11. The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $233.60 to $234.28.
12. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
Chad J. Wiener, as Attorney-in-fact for R. Scott Ramsey 03/03/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR